AI Diagnostics: The End of the High-Cost Imaging Era
(TSX-V:VPT),(NYSE:EW),(PinkSheets:VPTDF),(NASDAQ:CBLL),(NasdaqGM:ATRC),(NASDAQ:HTFL), VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) — Equity-Insider.com News Commentary – The AI medical imaging market is entering a phase of explosive 25.8% annual growth through 2034[1]. This systemic re-rating is driven by healthcare's structural pivot from bulky, expensive hardware to agile, software-defined intelligence. As diagnostics move out of specialized labs and […]